⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21114363 | 1.00 | ECE1 (0.50) | — | |
| SCHEMBL2035521 | 0.84 | PRMT1 (0.54) | — | |
| SCHEMBL2172441 | 0.82 | PRMT1 (0.64) | — | |
| Beta-Alanine SCHEMBL17165678 | 0.82 | ADRA1A (0.48) | — | |
| Pyrimidine SCHEMBL20898596 | 0.82 | RECQL (0.41) | — | |
| SCHEMBL9307514 | 0.80 | PRMT1 (0.68) | — | |
| SCHEMBL11039434 | 0.80 | PRMT1 (0.68) | — | |
| SCHEMBL2028710 | 0.80 | PRMT1 (0.68) | — | |
| SCHEMBL1326707 | 0.80 | — | — | |
| Ompenaclid SCHEMBL33761 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 978 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| EP-4692783-A1 | BIOMARKER AND SYSTEM FOR PREDICTING EVOLUTION INTO ACLF OR DEATH OF ACLF PATIENT, AND USES THEREOF | Shanghai Ganning Medical and Technology Co., Ltd (CN) | 2026-02-11 | — | — | EP | claimed |
| US-20250341515-A1 | METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | US | claimed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| US-12292445-B2 | Methods of selecting subjects for treatment with metabolomic modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-06 | — | — | US | claimed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | claimed |
| CN-119555822-A | Urine metabolism marker composition for diagnosis of cancer seeds of pan-cancer, screening method and application | 哈尔滨脉图精准技术有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119510604-A | Biomarker for predicting whether ACLF patient will die, system and application thereof | 上海甘宁医疗科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-20020132283-A1 | Composition for determining pyrimidine metabolizing activity | OTSUKA PHARMACEUTICAL CO. LTD. (JP) | 2002-09-19 | — | — | US | claimed |
| US-20020039990-A1 | Gene sequence variances in genes related to folate metabolism having utility in determining the treatment of disease | VARIAGENICS, INC. | 2002-04-04 | — | — | US | claimed |
| EP-1142995-A1 | ANTIURACIL MONOCLONAL ANTIBODY | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 2001-10-10 | — | — | EP | claimed |
| EP-0628637-B1 | PROCESS FOR PRODUCING D-ALPHA-AMINO ACIDS | KANEGAFUCHI CHEMICAL IND (JP) | 2001-06-13 | — | — | EP | claimed |
| EP-1100964-A1 | GENE SEQUENCE VARIANCES WITH UTILITY IN DETERMINING THE TREATMENT OF DISEASE | Variagenics, Inc. (US) | 2001-05-23 | — | — | EP | claimed |
| CN-1282329-A | I (ortho)-anthranilamide derivatives as anti-coagulants | SCHERING AG (DE) | 2001-01-31 | — | — | CN | claimed |
| WO-2000004194-A1 | GENE SEQUENCE VARIANCES WITH UTILITY IN DETERMINING THE TREATMENT OF DISEASE | VARIAGENICS, INC. (US) | 2000-01-27 | — | — | WO | claimed |
| US-5902736-A | USING DECARBAMYLASE FROM COMAMONAS, ALCALIGENES, RHIZOBIUM, BLASTOBACTER, SPOROSARCINA, AND BRADYRHYZOBIUM SPECIES IN AQUEOUS MEDIUM; AS CHEMICAL INTERMEDIATES FOR SEMISYNTHETIC PENICILLIN AND CEPHALOSPORIN | KANEGAFUCHI CHEMICAL INDUSTRY CO., LTD. (JP) | 1999-05-11 | — | — | US | claimed |
| EP-0628637-A1 | PROCESS FOR PRODUCING D-$g(a)-AMINO ACID | Kanegafuchi Chemical Industry Co., Ltd. (JP) | 1994-12-14 | — | — | EP | claimed |
| EP-0173276-A2 | Method for the determination of substrate or enzyme activity | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1986-03-05 | — | — | EP | claimed |